Old and new genes in primary aldosteronism

Area of Science:

• Endocrinology
• Genetics
• Cardiovascular Medicine

Background:

• Primary aldosteronism (PA) is the most frequent cause of secondary hypertension, impacting 5%-10% of hypertensive patients.
• PA is characterized by elevated aldosterone, low renin, and often hypokalemia, leading to high blood pressure.
• Autonomous aldosterone overproduction stems from aldosterone-producing adenomas (APA) or bilateral adrenal hyperplasia (BAH).

Purpose of the Study:

• To explore the genetic underpinnings of primary aldosteronism.
• To understand the role of somatic and germline mutations in APA and BAH.
• To identify novel therapeutic targets for PA based on genetic discoveries.

Main Methods:

• Targeted next-generation sequencing after immunohistochemistry-guided aldosterone synthase detection.
• Whole exome sequencing for familial PA.
• Identification of somatic mutations in aldosterone-producing cell clusters in BAH.

Main Results:

• Somatic mutations are detected in up to 90% of APA cases using targeted sequencing.
• Whole exome sequencing identified genetic causes for four distinct familial PA forms.
• Somatic mutations in aldosterone-producing cell clusters were found in BAH, advancing understanding of this form.

Conclusions:

• Genetic discoveries have significantly improved the understanding of PA pathophysiology.
• Targeted sequencing and whole exome sequencing are powerful tools for diagnosing PA subtypes.
• Identifying genetic drivers in BAH opens new avenues for developing targeted therapies for primary aldosteronism.